John Huggins to Placebos
This is a "connection" page, showing publications John Huggins has written about Placebos.
Connection Strength
0.191
-
Serious adverse events in patients with idiopathic pulmonary fibrosis in the placebo arms of 6 clinical trials. Respir Med. 2019 04; 150:120-125.
Score: 0.153
-
Lung function outcomes in the INPULSIS? trials of nintedanib in idiopathic pulmonary fibrosis. Respir Med. 2019 01; 146:42-48.
Score: 0.038